Biocitech : les entreprises du site ont déposé plus de 30 demandes de brevets en 2007

April 21, 2008
Grâce à ce chiffre, Biocitech se place au troisième
rang national des déposants dans le domaine des sciences de la
vie
. L’ « effet campus » a aussi suscité plus
d’une trentaine de partenariats entre les entreprises de
Biocitech

Biocitech, le 21 avril 2008 - Biocitech, le parc
technologique parisien dédié aux sciences de la vie, annonce aujourd’hui que les
entreprises qu’il héberge ont déposé plus de 30 demandes de brevets au cours de
l’année 2007. Ce chiffre positionne Biocitech en troisième position pour le
nombre de dépôts dans le domaine des sciences de la vie, derrière le CNRS et
sanofi-aventis, et parmi les 50 premiers déposants nationaux, selon le nombre de
brevets publiés pour l’an dernier. Il s’agit d’une illustration forte des
recherches et avancées scientifiques rendues possibles par l’effet de synergie
engendré entre les entreprises présentes sur le campus.

www.biocitech.com


Better finance for more enterprise growth in Europe

March 12, 2008
The corporate giants of Europe are aging elders. This column suggests financial reforms to encourage the growth of emerging
enterprises.

The recent financial turmoil will certainly lead policy-makers to reconsider existing regulations of financial markets and institutions. It would be misguided to focus exclusively on stability, however. What the European financial system lacks above all is the ability to foster the growth of emerging companies. According to Aghion, Fally and Scarpetta (2007), among others, financial development is particularly important for the entry and expansion of new businesses, possibly more so than labour market flexibility. We take this logic one step further and argue that some types of financial developments are more needed than others at this stage in the economic history of Europe.

The lack of emerging firms in Europe

Entry, exit, and the reallocation of resources among firms play a crucial role in the process of economic growth.1Europe’s corporate landscape, however, is dominated by old, established companies. A look at the age distribution of the world’s 500 largest listed companies shows that European ‘champions’ are generally much older than American ones, let alone those from emerging markets, as illustrated by Figure 1. Europe’s corporate giants include only 12 companies born in the second half of the 20th century, against 51 in the US and 46 in emerging countries.

More from VoxEU


Do you know Céline Héchard?

February 23, 2008

celineHechard· What is it you do?
I m in charge of I-STEM partnerships and business development. I-STEM (Institute for Stem Cells in the Treatment and Study of Monogenic Diseases) is involve in the evaluation of the full therapeutic potential of all types of human stem cells in the treatment of monogenic diseases. · What is your next exciting milestone?
The next exciting partnership for I-STEM scientists.

· Where will you spend you next holiday and why?
Morgins, Switzerland (http://www.morgins.ch) where my sister lives. We plan to have some ski and fun.

· Favorite bar in Paris? Another city (anywhere in the world)?
Restaurants : Le Balzac, Paris or Spoon, Paris


Do you know me?

January 22, 2008

PCHMaybe you do. However, this blog is not about me. I will post about people I meet, work with, have beers with, and exchange ideas, business cards, emails. Eventually this may give you an idea of what I do but more importantly it should tell who are the contributors to some of the most interesting and successful clusters in technology in Europe and the USA.
I must aknowledge that the idea of posting portraits came from Xavier Quillet’s blog. Xavier stopped posting last spring but had an interesting galery on French biotechnologists and entrepreneurs.